FUNDING CANCER - Exploratory/Developmental Bioengineering Research Grants (EBRG) (Multiple Mechanisms)
Sponsor: NIH
Multiple Mechanisms:
PAR-25-321, R21 Clinical Trial Optional
PAR-25-346, R21 Clinical Trial Not Allowed
Description: The purpose of this engineering-oriented NOFO is to encourage submissions of EBRG applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical research, pre-clinical research, clinical research, clinical care delivery, or care accessibility. This opportunity will support clinical trials that test functionality or validate performance in the chosen setting.
- Applications Due:
- February 16, 2025
- June 16, 2025
- October 16, 2025
- February 16, 2026
- June 16, 2026
- October 16, 2026
- February 16, 2027
- June 16, 2027
- October 16, 2027
To view all current UVACCC funding opportunities, please click here.
For all open cancer-related funding opportunities, please click here.
